Race Against the Bird Flu: Vaccine Trials and Global Efforts

The video discusses an experimental bird flu vaccine trial at the University of Rochester Medical Centre, highlighting its preliminary safety and effectiveness. The vaccine targets the H5N1 strain, prevalent in Asia and Europe, but may offer limited protection if the virus mutates. The US government has stockpiled 2 million doses, aiming to protect 20 million people, though production challenges remain. The pharmaceutical company Roche is donating Tamiflu to countries affected by H5N1 and has increased production, providing 3 million packs to the WHO.

How many doses of the vaccine has the US government stockpiled, and how many people can it protect?

What actions has the pharmaceutical firm Roche taken in response to the H5N1 avian flu strain?